Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients ; day:3 ; month:5 ; year:2024 ; pages:1-10
Bone marrow transplantation ; (3.5.2024), 1-10
- Creator
-
Berning, Philipp
Kolloch, Lina
Reicherts, Christian
Call, Simon
Marx, Julia
Floeth, Matthias
Esseling, Eva
Ronnacker, Julian
Albring, Jörn
Schliemann, Christoph
Lenz, Georg
Stelljes, Matthias
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41409-024-02295-2
- URN
-
urn:nbn:de:101:1-2407142124421.997577762903
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Berning, Philipp
- Kolloch, Lina
- Reicherts, Christian
- Call, Simon
- Marx, Julia
- Floeth, Matthias
- Esseling, Eva
- Ronnacker, Julian
- Albring, Jörn
- Schliemann, Christoph
- Lenz, Georg
- Stelljes, Matthias
- SpringerLink (Online service)
Other Objects (12)
Monosomie 7 bei Kindern mit AML und MDS
Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis
MDS, AML als sekundäre maligne Neoplasien bei Kindern und Jugendlichen
American Society of Hematology 2020 Podcast Collection: MDS and AML
Clostridium difficile Infektionen bei AML-/MDS-Patienten bei allogener hämatopoietischer Stammzelltransplantation
p53 biology and reactivation for improved therapy in MDS and AML
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells
Die Rolle verschiedener GFI1-Expressionslevel in der Progression von MDS und AML
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
TBI
Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Monosomie 7 bei Kindern mit AML und MDS
Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis
MDS, AML als sekundäre maligne Neoplasien bei Kindern und Jugendlichen
American Society of Hematology 2020 Podcast Collection: MDS and AML
Clostridium difficile Infektionen bei AML-/MDS-Patienten bei allogener hämatopoietischer Stammzelltransplantation
p53 biology and reactivation for improved therapy in MDS and AML
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells
Die Rolle verschiedener GFI1-Expressionslevel in der Progression von MDS und AML
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
TBI
Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Monosomie 7 bei Kindern mit AML und MDS
Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis
MDS, AML als sekundäre maligne Neoplasien bei Kindern und Jugendlichen
American Society of Hematology 2020 Podcast Collection: MDS and AML
Clostridium difficile Infektionen bei AML-/MDS-Patienten bei allogener hämatopoietischer Stammzelltransplantation
p53 biology and reactivation for improved therapy in MDS and AML
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells
Die Rolle verschiedener GFI1-Expressionslevel in der Progression von MDS und AML
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML
TBI